Annual Revenue
$14.09 M
-$88.60 M-86.28%
31 December 2023
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares annual revenue is currently $14.09 million, with the most recent change of -$88.60 million (-86.28%) on 31 December 2023. NAMS annual revenue is now -86.28% below its all-time high of $102.69 million, reached on 31 December 2022.NAMS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$29.11 M
+$26.83 M+1177.36%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares quarterly revenue is currently $29.11 million, with the most recent change of +$26.83 million (+1177.36%) on 30 September 2024. Over the past year, it has increased by +$26.17 million (+889.83%). NAMS quarterly revenue is now at all-time high.NAMS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$33.59 M
+$26.17 M+352.51%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares TTM revenue is currently $33.59 million, with the most recent change of +$26.17 million (+352.51%) on 30 September 2024. Over the past year, it has increased by +$20.31 million (+152.83%). NAMS TTM revenue is now at all-time high.NAMS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAMS Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.3% | +889.8% | +152.8% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
NAMS Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -86.3% | at low | at high | +3525.3% | at high | +389.6% |
| 5 y | 5 years | -86.3% | at low | at high | +3525.3% | at high | +389.6% |
| alltime | all time | -86.3% | at low | at high | +3525.3% | at high | +389.6% |
NewAmsterdam Pharma Company NV Ordinary Shares Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $29.11 M(+1177.4%) | $33.59 M(+352.5%) |
| June 2024 | - | $2.28 M(+62.7%) | $7.42 M(+8.2%) |
| Mar 2024 | - | $1.40 M(+74.5%) | $6.86 M(-51.3%) |
| Dec 2023 | $14.09 M | $803.00 K(-72.7%) | $14.09 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $2.94 M(+71.3%) | $13.29 M(+28.4%) |
| June 2023 | - | $1.72 M(-80.1%) | $10.35 M(+19.9%) |
| Mar 2023 | - | $8.63 M | $8.63 M |
| Dec 2022 | $102.69 M | - | - |
FAQ
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual revenue?
- What is the all time high annual revenue for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual revenue year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly revenue?
- What is the all time high quarterly revenue for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly revenue year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares TTM revenue?
- What is the all time high TTM revenue for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares TTM revenue year-on-year change?
What is NewAmsterdam Pharma Company NV Ordinary Shares annual revenue?
The current annual revenue of NAMS is $14.09 M
What is the all time high annual revenue for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high annual revenue is $102.69 M
What is NewAmsterdam Pharma Company NV Ordinary Shares annual revenue year-on-year change?
Over the past year, NAMS annual revenue has changed by -$88.60 M (-86.28%)
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly revenue?
The current quarterly revenue of NAMS is $29.11 M
What is the all time high quarterly revenue for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high quarterly revenue is $29.11 M
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly revenue year-on-year change?
Over the past year, NAMS quarterly revenue has changed by +$26.17 M (+889.83%)
What is NewAmsterdam Pharma Company NV Ordinary Shares TTM revenue?
The current TTM revenue of NAMS is $33.59 M
What is the all time high TTM revenue for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high TTM revenue is $33.59 M
What is NewAmsterdam Pharma Company NV Ordinary Shares TTM revenue year-on-year change?
Over the past year, NAMS TTM revenue has changed by +$20.31 M (+152.83%)